Skip to content
10-Q

Quarterly Report

NP Life Sciences Health Industry Group Inc. ACAT

0001493152-21-029587

← back to feed
Filed
Nov 22, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Sep 30, 2021 42.96M sh
Cash And Equivalents Q3 2021 · Sep 30, 2021 $25.01K
Cash And Equivalents Q3 2021 · Dec 31, 2020 $118.61K
Total Liabilities Q3 2021 · Sep 30, 2021 $19.11K
Total Liabilities Q3 2021 · Dec 31, 2020 $14.76K
Total Assets Q3 2021 · Sep 30, 2021 $25.01K
Total Assets Q3 2021 · Dec 31, 2020 $118.61K
Operating Cash Flow Q3 2021 · Sep 30, 2020 −$97.94K
Stockholders Equity Q3 2021 · Sep 30, 2020 $125.51K
Stockholders Equity Q3 2021 · Dec 31, 2019 $234.91K
Sga Expense Q3 2021 · Sep 30, 2020 $25.64K
Sga Expense Q3 2021 · Sep 30, 2020 $124.43K
Net Income restated Q3 2021 · Sep 30, 2020 −$25.64K
Net Income Q3 2021 · Sep 30, 2020 −$109.41K
Operating Income Q3 2021 · Sep 30, 2020 −$25.64K
Operating Income Q3 2021 · Sep 30, 2020 −$109.43K
Revenue Q3 2021 · Sep 30, 2020 $15K